logo-loader
viewArcher Daniels Midland

Archer Daniels lower after third quarter misses Wall Street expectations

CEO Juan Luciano admitted: “Our third quarter results were below our expectations, as the operating environment in our ag services and oilseeds businesses was more challenging than anticipated"

corn
The company is transitioning to "lower capital spending and increasing benefits from these investments."

Archer Daniels Midland Co. (NYSE:ADM) shares eased early trade, after its third quarter failed to live up to Wall Street’s expectations.

One of the world’s biggest crop traders and processors, said net earnings during the quarter came in at US$192mln, or 34 US cents per share, down from the US$341mln, or 58 US cents, reported the previous year.

Adjusted EPS stood at 45 US cents, missing market expectations for 55 US cents.

In the same period, revenue stood at US$14.83bn, down from US$15.83bn recorded the year before. It was also off analysts’ consensus for US$16.04bn.

Operating environment more challenging than expected

During the quarter, oilseeds processing revenue came to US$5.75bn, lower from the US$5.78 billion, reported earlier and again below market expectations for US$6.19bn.

CEO Juan Luciano admitted in a statement released Tuesday: “Our third quarter results were below our expectations, as the operating environment in our ag services and oilseeds businesses was more challenging than anticipated."

He also said the company is transitioning to "lower capital spending and increasing benefits from these investments."

Its shares were down 5.89% at US$40.29.

Quick facts: Archer Daniels Midland

Price: 39.67 USD

NYSE:ADM
Market: NYSE
Market Cap: $22.04 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Integumen PLC to test anti-viral skin and dental products through tie-up...

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott after announcing its subsidiary Labskin has partnered with the University of Aberdeen to test anti-viral skin and dental products that might mitigate the transmission risk of the coronavirus...

2 hours, 49 minutes ago

2 min read